Market Tracker

07/22 6:45pm ET

Aegerion Pharmaceuticals Inc (NASDAQ:AEGR)

1.46
Delayed Data
As of Jul 22
 -0.03 / -2.01%
Today’s Change
1.23
Today|||52-Week Range
20.45
-85.54%
Year-to-Date

Today’s Trading

Previous close1.49
Today’s open1.48
Day’s range1.46 - 1.50
Volume160,246
Average volume (3 months)883,664
Market cap$43.1M
Dividend yield--
Data as of 3:59pm ET, 07/22/2016

Growth & Valuation

Earnings growth (last year)-88.89%
Earnings growth (this year)-66.86%
Earnings growth (next 5 years)+15.84%
Revenue growth (last year)+51.47%
P/E ratioNM
Price/Sales1.21
Price/Book0.37

Competitors

 Today’s
change
Today’s
% change
PZRXPhaseRx Inc0.000.00%
FATEFate Therapeutics In...+0.03+2.10%
VSTMVerastem Inc-0.01-0.76%
APTOAptose Biosciences I...-0.08-3.07%
Data as of 3:59pm ET, 07/22/2016

Financials

Next reporting dateJuly 26, 2016
EPS forecast (this quarter)-$0.73
Annual revenue (last year)$239.9M
Annual profit (last year)-$73.3M
Net profit margin-30.57%

Profile

Sector
Health Technology
Industry
Biotechnology
Chief Executive Officer &
Director
Mary J. Szela
Chief Financial &
Administrative Officer
Gregory D. Perry
Corporate headquarters
Cambridge, Massachusetts

Forecasts